Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Impact of Huntington's Disease on quality of life

Identifieur interne : 002A12 ( PascalFrancis/Corpus ); précédent : 002A11; suivant : 002A13

Impact of Huntington's Disease on quality of life

Auteurs : D. I. Helder ; A. A. Kaptein ; G. M. J. Van Kempen ; J. C. Van Houwelingen ; R. A. C. Roos

Source :

RBID : Pascal:01-0335232

Descripteurs français

English descriptors

Abstract

The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 16
A06       @2 2
A08 01  1  ENG  @1 Impact of Huntington's Disease on quality of life
A11 01  1    @1 HELDER (D. I.)
A11 02  1    @1 KAPTEIN (A. A.)
A11 03  1    @1 VAN KEMPEN (G. M. J.)
A11 04  1    @1 VAN HOUWELINGEN (J. C.)
A11 05  1    @1 ROOS (R. A. C.)
A14 01      @1 Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC) @3 NLD @Z 1 aut. @Z 2 aut. @Z 3 aut.
A14 02      @1 Department of Medical Statistics, Leiden University Medical Centre (LUMC) @3 NLD @Z 4 aut.
A14 03      @1 Department of Neurology, Leiden University Medical Centre (LUMC) @3 NLD @Z 5 aut.
A20       @1 325-330
A21       @1 2001
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000096545190230
A44       @0 0000 @1 © 2001 INIST-CNRS. All rights reserved.
A45       @0 24 ref.
A47 01  1    @0 01-0335232
A60       @1 P @3 CC
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Chorée Huntington @5 01
C03 01  X  ENG  @0 Huntington disease @5 01
C03 01  X  SPA  @0 Corea Huntington @5 01
C03 02  X  FRE  @0 Qualité vie @5 04
C03 02  X  ENG  @0 Quality of life @5 04
C03 02  X  SPA  @0 Calidad vida @5 04
C03 03  X  FRE  @0 Sickness Impact Profile Gilson @2 NP @5 07
C03 03  X  ENG  @0 Sickness Impact Profile Gilson @2 NP @5 07
C03 03  X  SPA  @0 Sickness Impact Profile Gilson @2 NP @5 07
C03 04  X  FRE  @0 Bien être psychologique @5 10
C03 04  X  ENG  @0 Psychological well being @5 10
C03 04  X  SPA  @0 Bienestar psicológico @5 10
C03 05  X  FRE  @0 Effet psychologique @5 17
C03 05  X  ENG  @0 Psychological effect @5 17
C03 05  X  SPA  @0 Efecto psicológico @5 17
C03 06  X  FRE  @0 Psychométrie @5 18
C03 06  X  ENG  @0 Psychometrics @5 18
C03 06  X  SPA  @0 Psicometría @5 18
C03 07  X  FRE  @0 Adulte @5 20
C03 07  X  ENG  @0 Adult @5 20
C03 07  X  SPA  @0 Adulto @5 20
C07 01  X  FRE  @0 Homme
C07 01  X  ENG  @0 Human
C07 01  X  SPA  @0 Hombre
C07 02  X  FRE  @0 Système nerveux pathologie @5 37
C07 02  X  ENG  @0 Nervous system diseases @5 37
C07 02  X  SPA  @0 Sistema nervioso patología @5 37
C07 03  X  FRE  @0 Système nerveux central pathologie @5 38
C07 03  X  ENG  @0 Central nervous system disease @5 38
C07 03  X  SPA  @0 Sistema nervosio central patología @5 38
C07 04  X  FRE  @0 Encéphale pathologie @5 39
C07 04  X  ENG  @0 Cerebral disorder @5 39
C07 04  X  SPA  @0 Encéfalo patología @5 39
C07 05  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 05  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 05  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 06  X  FRE  @0 Maladie dégénérative @5 41
C07 06  X  ENG  @0 Degenerative disease @5 41
C07 06  X  SPA  @0 Enfermedad degenerativa @5 41
C07 07  X  FRE  @0 Maladie héréditaire @5 42
C07 07  X  ENG  @0 Genetic disease @5 42
C07 07  X  SPA  @0 Enfermedad hereditaria @5 42
N21       @1 232

Format Inist (serveur)

NO : PASCAL 01-0335232 INIST
ET : Impact of Huntington's Disease on quality of life
AU : HELDER (D. I.); KAPTEIN (A. A.); VAN KEMPEN (G. M. J.); VAN HOUWELINGEN (J. C.); ROOS (R. A. C.)
AF : Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)/Pays-Bas (1 aut., 2 aut., 3 aut.); Department of Medical Statistics, Leiden University Medical Centre (LUMC)/Pays-Bas (4 aut.); Department of Neurology, Leiden University Medical Centre (LUMC)/Pays-Bas (5 aut.)
DT : Publication en série; Courte communication, note brève; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2001; Vol. 16; No. 2; Pp. 325-330; Bibl. 24 ref.
LA : Anglais
EA : The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.
CC : 002B17G
FD : Chorée Huntington; Qualité vie; Sickness Impact Profile Gilson; Bien être psychologique; Effet psychologique; Psychométrie; Adulte
FG : Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Maladie héréditaire
ED : Huntington disease; Quality of life; Sickness Impact Profile Gilson; Psychological well being; Psychological effect; Psychometrics; Adult
EG : Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Genetic disease
SD : Corea Huntington; Calidad vida; Sickness Impact Profile Gilson; Bienestar psicológico; Efecto psicológico; Psicometría; Adulto
LO : INIST-20953.354000096545190230
ID : 01-0335232

Links to Exploration step

Pascal:01-0335232

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Impact of Huntington's Disease on quality of life</title>
<author>
<name sortKey="Helder, D I" sort="Helder, D I" uniqKey="Helder D" first="D. I." last="Helder">D. I. Helder</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kaptein, A A" sort="Kaptein, A A" uniqKey="Kaptein A" first="A. A." last="Kaptein">A. A. Kaptein</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Kempen, G M J" sort="Van Kempen, G M J" uniqKey="Van Kempen G" first="G. M. J." last="Van Kempen">G. M. J. Van Kempen</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Houwelingen, J C" sort="Van Houwelingen, J C" uniqKey="Van Houwelingen J" first="J. C." last="Van Houwelingen">J. C. Van Houwelingen</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Medical Statistics, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">01-0335232</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 01-0335232 INIST</idno>
<idno type="RBID">Pascal:01-0335232</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002A12</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Impact of Huntington's Disease on quality of life</title>
<author>
<name sortKey="Helder, D I" sort="Helder, D I" uniqKey="Helder D" first="D. I." last="Helder">D. I. Helder</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kaptein, A A" sort="Kaptein, A A" uniqKey="Kaptein A" first="A. A." last="Kaptein">A. A. Kaptein</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Kempen, G M J" sort="Van Kempen, G M J" uniqKey="Van Kempen G" first="G. M. J." last="Van Kempen">G. M. J. Van Kempen</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Van Houwelingen, J C" sort="Van Houwelingen, J C" uniqKey="Van Houwelingen J" first="J. C." last="Van Houwelingen">J. C. Van Houwelingen</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Medical Statistics, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Huntington disease</term>
<term>Psychological effect</term>
<term>Psychological well being</term>
<term>Psychometrics</term>
<term>Quality of life</term>
<term>Sickness Impact Profile Gilson</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Chorée Huntington</term>
<term>Qualité vie</term>
<term>Sickness Impact Profile Gilson</term>
<term>Bien être psychologique</term>
<term>Effet psychologique</term>
<term>Psychométrie</term>
<term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>16</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Impact of Huntington's Disease on quality of life</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>HELDER (D. I.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>KAPTEIN (A. A.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>VAN KEMPEN (G. M. J.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>VAN HOUWELINGEN (J. C.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>ROOS (R. A. C.)</s1>
</fA11>
<fA14 i1="01">
<s1>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Medical Statistics, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Department of Neurology, Leiden University Medical Centre (LUMC)</s1>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20>
<s1>325-330</s1>
</fA20>
<fA21>
<s1>2001</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000096545190230</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>24 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>01-0335232</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Chorée Huntington</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Huntington disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Corea Huntington</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Qualité vie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Quality of life</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Calidad vida</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Sickness Impact Profile Gilson</s0>
<s2>NP</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Sickness Impact Profile Gilson</s0>
<s2>NP</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sickness Impact Profile Gilson</s0>
<s2>NP</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Bien être psychologique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Psychological well being</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Bienestar psicológico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Effet psychologique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Psychological effect</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Efecto psicológico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Psychométrie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Psychometrics</s0>
<s5>18</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Psicometría</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Maladie héréditaire</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Genetic disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Enfermedad hereditaria</s0>
<s5>42</s5>
</fC07>
<fN21>
<s1>232</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 01-0335232 INIST</NO>
<ET>Impact of Huntington's Disease on quality of life</ET>
<AU>HELDER (D. I.); KAPTEIN (A. A.); VAN KEMPEN (G. M. J.); VAN HOUWELINGEN (J. C.); ROOS (R. A. C.)</AU>
<AF>Medical Psychology, Department of Psychiatry, Leiden University Medical Centre (LUMC)/Pays-Bas (1 aut., 2 aut., 3 aut.); Department of Medical Statistics, Leiden University Medical Centre (LUMC)/Pays-Bas (4 aut.); Department of Neurology, Leiden University Medical Centre (LUMC)/Pays-Bas (5 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2001; Vol. 16; No. 2; Pp. 325-330; Bibl. 24 ref.</SO>
<LA>Anglais</LA>
<EA>The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP), Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, hut not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed.</EA>
<CC>002B17G</CC>
<FD>Chorée Huntington; Qualité vie; Sickness Impact Profile Gilson; Bien être psychologique; Effet psychologique; Psychométrie; Adulte</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Maladie héréditaire</FG>
<ED>Huntington disease; Quality of life; Sickness Impact Profile Gilson; Psychological well being; Psychological effect; Psychometrics; Adult</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Genetic disease</EG>
<SD>Corea Huntington; Calidad vida; Sickness Impact Profile Gilson; Bienestar psicológico; Efecto psicológico; Psicometría; Adulto</SD>
<LO>INIST-20953.354000096545190230</LO>
<ID>01-0335232</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A12 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002A12 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:01-0335232
   |texte=   Impact of Huntington's Disease on quality of life
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024